Tractor Supply Company (TSCO) reported its Q1 2025 results and has provided guidance for Q2, widening its 2025 sales range. Compensation for TSCO's CEO is perceived as fair. Several major firms, including
AXA S.A,
AQR Capital Management, and
BNP Paribas have been increasing their stake in
TSCO. Meanwhile, there's an impact from tariffs as the company sources overseas, raising costs. TSCO is innovating by launching the Tractor Supply Rx, facilitating pet pharmacy offerings. Q2 EPS is expected to surpass consensus, giving a boost to the FY10 outlook. The stock performed better than its underlying earnings growth over the last five years. Dividend investors are taking an interest in TSCO with its high and persistent dividend growth. The company also announced a webcast of its Q1 earnings conference call. However, Q1 Earnings lagged, causing share prices to fall. The company is also expanding, spending $225M on an Idaho expansion, creating 500 new jobs. TSCO acquired Allivet, an online pet and animal pharmacy, amid plans of aggressive domestic expansion. The company maintained margins while funding growth.
Tractor Supply Co TSCO News Analytics from Thu, 08 Aug 2024 07:00:00 GMT to Sat, 10 May 2025 13:53:53 GMT -
Rating 7
- Innovation 3
- Information 9
- Rumor -1
